Australian Clinical Labs Ltd
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veter… Read more
Australian Clinical Labs Ltd (ACL) - Total Assets
Latest total assets as of December 2025: AU$562.50 Million AUD
Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) holds total assets worth AU$562.50 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Australian Clinical Labs Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Australian Clinical Labs Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Australian Clinical Labs Ltd's total assets of AU$562.50 Million consist of 20.9% current assets and 79.1% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$21.44 Million | 3.7% |
| Accounts Receivable | AU$70.33 Million | 12.2% |
| Inventory | AU$15.62 Million | 2.7% |
| Property, Plant & Equipment | AU$270.11 Million | 47.0% |
| Intangible Assets | AU$6.10 Million | 1.1% |
| Goodwill | AU$159.11 Million | 27.7% |
Asset Composition Trend (2016–2025)
This chart illustrates how Australian Clinical Labs Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Australian Clinical Labs Ltd's current assets represent 20.9% of total assets in 2025, a decrease from 48.3% in 2016.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 5.8% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 10.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 47.0% of total assets.
Australian Clinical Labs Ltd Competitors by Total Assets
Key competitors of Australian Clinical Labs Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Australian Clinical Labs Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Australian Clinical Labs Ltd generates 1.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Australian Clinical Labs Ltd generates $5.64 in net profit.
Australian Clinical Labs Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.59 | 0.58 |
| Quick Ratio | 0.50 | 0.51 | 0.50 |
| Cash Ratio | 0.11 | 0.10 | 0.19 |
| Working Capital | AU$-81.50 Million | AU$ -85.67 Million | AU$ -77.16 Million |
Australian Clinical Labs Ltd - Advanced Valuation Insights
This section examines the relationship between Australian Clinical Labs Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.78 |
| Latest Market Cap to Assets Ratio | 0.38 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | AU$574.84 Million |
| Market Capitalization | $217.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Australian Clinical Labs Ltd's assets below their book value (0.38 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Australian Clinical Labs Ltd's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Australian Clinical Labs Ltd (2016–2025)
The table below shows the annual total assets of Australian Clinical Labs Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$574.84 Million | 0.00% |
| 2024-12-31 | AU$574.84 Million | -3.07% |
| 2024-06-30 | AU$593.06 Million | 0.00% |
| 2023-12-31 | AU$593.06 Million | +2.44% |
| 2023-06-30 | AU$578.91 Million | 0.00% |
| 2022-12-31 | AU$578.91 Million | -7.82% |
| 2022-06-30 | AU$628.04 Million | 0.00% |
| 2021-12-31 | AU$628.04 Million | +32.30% |
| 2021-06-30 | AU$474.70 Million | 0.00% |
| 2020-12-31 | AU$474.70 Million | +29.68% |
| 2020-06-30 | AU$366.05 Million | 0.00% |
| 2019-12-31 | AU$366.05 Million | +138.30% |
| 2019-06-30 | AU$153.61 Million | 0.00% |
| 2018-12-31 | AU$153.61 Million | +29.02% |
| 2018-06-30 | AU$119.06 Million | 0.00% |
| 2017-12-31 | AU$119.06 Million | -1.52% |
| 2017-06-30 | AU$120.89 Million | 0.00% |
| 2016-12-31 | AU$120.89 Million | -- |